Company
United StatesPublic company, NYSE: MDTMedtronic (NYSE: MDT), Louisville, KY – FDA Inspections
Inspection records and compliance data for Medtronic in Louisville, Kentucky. 1 FDA inspection on record, last inspected March 15, 2011. Publicly traded as NYSE: MDT.
Company Profile
This profile covers Medtronic based in Louisville, Kentucky, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected March 15, 2011.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 15, 2011 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 715009 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Medtronic
Stock ticker
MDT
Exchange
NYSE
Share price
$105.03
Market cap
$134.3B
Price as of
November 6, 2026
FEI Number
3004104136
Address
9300 Shelbyville Rd Ste 1025, Louisville, Kentucky 40222, United States
Country
United States
ID: 4a1b025c-4f5e-4135-b2f3-855b5afad8b6